This is not a government agency sharing risk, it’s a government agency assuming virtually all of the risk associated with the higher premium costs due to the rebate rule. In other words, a bailout.
While such costs represent a small fraction of overall spending on health care, several dynamics help the prescription drug issue gain disproportionate attention.
Here’s a solution: stop focusing on trying to control prescription drug prices, and start paying attention to who’s paying them.
In fact, Sen. Bernie Sanders is one of the most blatantly dishonest politicians on either side of the aisle, particularly on health care.
While the public hold little sympathy for Big Pharma, when the drug industry suffers, people suffer. And when Big Pharma wins, people win.
On Wednesday, a Senate committee will hold a hearing on President Trump’s appointment of Dr. Scott Gottlieb as commissioner of the Food and Drug Administration.
Watch out for five misguided attacks to persuade the public that government intervention in the pharmaceutical industry is necessary. Actually, it will make things worse.
- 5 Times The Mueller Probe Broke Prosecutorial Rules That Ensure JusticeThere are rules against using the power and authority ocontinue reading >
- Father Gagged, Found Guilty Of ‘Family Violence’ For Calling His Trans Daughter A ‘She’British Columbia's Supreme Court declared a father guilcontinue reading >
- I Fought In The Battle Of Mogadishu. Here’s What Rep. Ilhan Omar Gets Wrong About ‘Black Hawk Down’ Omar enjoys the fruits of American combat deaths, yet continue reading >